- Home
- CHRS vs BZUN Comparison
CHRS vs BZUN Comparison
Compare CHRS & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- BZUN
- Stock Information
- Founded
- CHRS 2010
- BZUN 2007
- Country
- CHRS United States
- BZUN China
- Employees
- CHRS N/A
- BZUN N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- BZUN Catalog/Specialty Distribution
- Sector
- CHRS Health Care
- BZUN Consumer Discretionary
- Exchange
- CHRS Nasdaq
- BZUN Nasdaq
- Market Cap
- CHRS 159.2M
- BZUN 275.9M
- IPO Year
- CHRS 2014
- BZUN N/A
- Fundamental
- Price
- CHRS $1.32
- BZUN $4.46
- Analyst Decision
- CHRS Strong Buy
- BZUN Strong Buy
- Analyst Count
- CHRS 4
- BZUN 1
- Target Price
- CHRS $4.51
- BZUN $4.20
- AVG Volume (30 Days)
- CHRS 1.2M
- BZUN 703.4K
- Earning Date
- CHRS 11-05-2025
- BZUN 08-28-2025
- Dividend Yield
- CHRS N/A
- BZUN N/A
- EPS Growth
- CHRS N/A
- BZUN N/A
- EPS
- CHRS 1.55
- BZUN N/A
- Revenue
- CHRS $272,209,000.00
- BZUN $1,349,630,922.00
- Revenue This Year
- CHRS N/A
- BZUN $5.27
- Revenue Next Year
- CHRS $109.48
- BZUN $3.46
- P/E Ratio
- CHRS $2.52
- BZUN N/A
- Revenue Growth
- CHRS 52.33
- BZUN 7.73
- 52 Week Low
- CHRS $0.66
- BZUN $2.12
- 52 Week High
- CHRS $2.43
- BZUN $4.88
- Technical
- Relative Strength Index (RSI)
- CHRS 63.67
- BZUN 68.26
- Support Level
- CHRS $1.23
- BZUN $3.74
- Resistance Level
- CHRS $1.40
- BZUN $4.88
- Average True Range (ATR)
- CHRS 0.07
- BZUN 0.35
- MACD
- CHRS -0.00
- BZUN 0.10
- Stochastic Oscillator
- CHRS 74.19
- BZUN 80.32
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.